BioCentury | Jul 9, 2020
Product Development
CSL testing coagulation factor blocker in COVID-19 patients; plus vaccine deals and plasma trials
...for Epidemic Preparedness Innovations (CEPI)
GlaxoSmithKline plc
Dynavax Technologies Corp.
Medicago Inc.
Emergent BioSolutions Inc.
Mount Sinai Hospital
U.S. Department of Defense
Erasmus MC Biomedical
Gilead...